Men and women infertility research hub

A double-blind, randomized, placebo-controlled, dose-escalating Phase I trial to determine the safety, pharmacokinetic parameters, and clinical effects of single subcutaneous injections of IGX12 in healthy female and male participants

This study is testing a new medicine, IGX12, for the first time in people. It aims to see if single injections of IGX12 are safe for healthy men and women, how the body handles the medicine, and if it has any effects. This research could help people with infertility in the future.